Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy
Velja Mijatovic, Sebastiaan Veersema, Mark Hans Emanuel, Roel Schats, Peter G A Hompes, Velja Mijatovic, Sebastiaan Veersema, Mark Hans Emanuel, Roel Schats, Peter G A Hompes
Abstract
Objective: To investigate the success rate of proximal tubal occlusion with Essure devices in subfertile women with hydrosalpinges, and to observe the results of subsequent treatment with IVF.
Design: Prospective, single-arm, clinical study.
Setting: University hospital and teaching hospital.
Patient(s): Ten women with uni- or bilateral hydrosalpinges prior to IVF. In all patients laparoscopy was felt to be contraindicated.
Intervention(s): Hysteroscopic placement of Essure devices in an office setting.
Main outcome measure(s): Placement rate, successful proximal tubal occlusion, and pregnancy rate after IVF.
Result(s): All patients had successful placement of the Essure devices without any complications. Proximal tubal occlusion was confirmed by hysterosalpingography in 9 out of 10 patients. A 40% ongoing pregnancy rate was achieved with 20% life births after one IVF cycle and/or frozen embryo transfer.
Conclusion(s): Proximal occlusion of hydrosalpinges with Essure devices before IVF is a successful treatment for patients with a contraindication for salpingectomy.
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Source: PubMed